(I-1C.4) Overlap cardiomyopathy – coexistence of hypertrophic and restrictive cardiomyopathy phenotypes in one patient Sylwia Wiśniowska-Śmałek MD, Paweł Rubiś MD, PhD, Monika Dzieciuch- Rojek, Dawid Kudliński MD, Agata Leśniak-Sobelga MD, PhD, Magdalena Kostkiewicz MD, PhD Prof. Piotr Podolec MD, PhD

 

BRIEF COMMENTS

EXPERT: Prof. Roland Hetzer, MD, PhD
Affiliation: German Heart Instiute, Berlin, Germany
COMMENT
Considering clinical data and results of the medical tests the patient is likely a future heart transplantation candidate. No relevant ventricular arrhythmias were detected and I would not recommend ICD implantation. However due to coexistent scoliosis the patient should undergo lung function tests and pulmonological consultation to plan the best possible post-op management. The scoliosis itself is not a contraindication to HTx.

EXPERT: Assoc. Prof. Bogusław Kapelak, MD, PhD
Affiliation: Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital, Krakow, Poland
COMMENT
The patient should remain in systematic medical observation. It is recommended to estimate the scoliosis impact on lung function and the patient’s exercise tolerance and asses possible risk of pulmonary failure if the heart transplantation is unavoidable.

EXPERT: Prof. Egle Ereminiene, MD, PhD
Affiliation: Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania
COMMENT
Current medical treatment should include higher doses of diuretics (due to high PCWP). The patient is a likely candidate for HTX in the future especially if VO2/kg max decrease is detected. I advise frequent follow-up evaluation.

CONCLUSIONS

1. The patient should undergo frequent follow-up evaluation with TTE and CPX chek-up.
2. It is recommended the patient is consulted by a pulmonary specialist and lung function tests should be performed.
3. Heart transplantation should be considered if the patient’s condition deteriorates (especially if VO2/kg max parameter decreases ).

“Development of the European Network in Orphan Cardiovascular Diseases”
„Rozszerzenie Europejskiej Sieci Współpracy ds. Sierocych Chorób Kardiologicznych”

This entry was posted in 1. Anatomical malformations of the arteries, 4. Coronary fistula, C. Coronary arteries, Case presentations, I. Rare diseases of systemic circulation. Bookmark the permalink.

Comments are closed.